We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

AI-related deals in the pharmaceutical sector grew by 14% compared to the same period in 2023. This year, AI is expected to ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 11.65%, which has investors questioning if this is right ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

Sara Klein was promoted to chief legal officer at Alumis, a clinical stage biopharmaceutical company, according to a Tuesday announcement.

Theravance Biopharma Inc . (NASDAQ:TBPH) stock reached a 52-week high this week, touching $10.47 amid a fluctuating market.

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, today announced that it has secured a $30 million ...

Looking ahead to 2025, small biopharma will continue its deliberate and ROI-driven approach to technology adoption. At the ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

The biopharma industry is highly dynamic and competitive. Companies that succeed in it must be able to tackle various aspects, including finances, marketing, regulations, investor relations, ...